Ashwani Kumar Concludes His Tenure As CEO & MD Of UCO Bank
UCO Bank Chief Executive Officer and Managing Director (CEO & MD) Ashwani Kumar ceased to hold office effective May 31, 2026, following the completion of his three-year tenure.
Lohit Bhatia Appointed As Executive Director & Group CEO Of Quess Corp
Quess Corp Limited has appointed Lohit Bhatia as Executive Director and Group Chief Executive Officer (GCEO), effective June 1, 2026.
Paresh Nath Sharma Reappointed As Independent Director Of Uflex
Paresh Nath Sharma has been reappointed as an Independent Director of Uflex Limited for the second term of five consecutive years, with effect from February 11, 2027.
Rajinder Singh Manku Joins Panacea Biotec As Independent Director
Rajinder Singh Manku has been appointed as a Non-Executive Independent Director of Panacea Biotec Limited, w.e.f. July 1, 2026, subject to approval of shareholders.
Sachin Naik Steps Down As CFO Of Shalimar Paints
Sachin Naik has resigned from the position of Chief Financial Officer and Key Managerial Personnel (CFO & KMP) of Shalimar Paints Limited, with effect from May 30, 2026, due to better career opportunities and professional growth prospects.
Hindustan Zinc Reappoints Arun Misra As Whole Time Director & CEO
The Board of Directors of Hindustan Zinc Limited has approved the extension of the tenure of Arun Misra as Chief Executive Officer (CEO) and Whole-time Director for a period of 2 months w.e.f. June 01, 2026, to July 31, 2026.
Lumax Auto Technologies Appoints Deepak Jain As Non-Executive Vice Chairman
The Board of Directors of Lumax Auto Technologies Limited has approved the change in designation of Deepak Jain from Non-Executive Director to Vice Chairman (Non-Executive), w.e.f. May 29, 2026.
Peninsula Land Reappoints Pawan Swamy As Independent Director; Nandan A Piramal As Joint MD
The Board of Directors of Peninsula Land Limited approved the re-designation of Nandan A Piramal from Whole-time Director to Managing Director, designated as ‘Joint Managing Director’.
Glenmark Pharmaceuticals Appoints Rashmi Khandelwal As Company Secretary
The Board of Directors of Glenmark Pharmaceuticals Limited has approved the appointment of Rashmi Khandelwal as Company Secretary and Compliance Officer (Key Managerial Personnel) effective from May 30, 2026, replacing Harish Kuber.
SEBI Slaps Rs 29 Crore Penalty on Suzlon Energy for Misleading Financial Statements
The Capital market regulator, the Securities and Exchange Board of India (SEBI), has imposed penalties totaling Rs. 28.95 crore on Suzlon Energy, its Chairman and Managing Director Vinod R. Tanti; promoter Girish R. Tanti, and other top executives.
